Bit Bio teams up with Abcam to supply cells to life science research community

The first product available is brain cells serving the neuroscience community.

Abcam -

Cell coding specialist Bit Bio has signed an agreement with AIM-listed reagent distributor Abcam to make its iPSC derived functional human cells available to the global life science community.

The first product available is brain cells serving the neuroscience community.

Bit Bio is addressing access to human cells, a significant bottleneck in medical research and drug development, through a precise reprogramming proprietary technology platform that enables uniquely efficient and consistent production of human cells.

“Bit Bio’s goal is to develop a scalable technology platform capable of producing consistent batches of every human cell type,” said Bit Bio chief executive Mark Kotter, a neurosurgeon at Cambridge University, and stem cell biologist.

“This agreement will accelerate our mission of putting highly defined human cells in the hands of the researchers who need them to pursue their life-saving work.”

“Supporting enhanced access to complementary technologies that have the potential to improve and accelerate research is part of our growth strategy,” said John Baker, Senior Vice President Product Portfolio and Innovation at Abcam.

Quick facts: Abcam

Price: 1441 GBX

Market: AIM
Market Cap: £3.12 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Trump Vs Biden debate: Market reaction, corporate support and future predictions

Neil Wilson from Markets.com joins Proactive London's Katie Pilbeam following the U.S. President Donald Trump and Democratic rival Joe Biden debate on Thursday night. With 47 million Americans already voted - do the markets even care? Wilson says there was 'no killer blow' which would explain...

1 day, 3 hours ago

2 min read